Research reveals the gut microbiota-brain axis as a critical link in understanding and treating neurological disorders through microbial interventions.
MAPS Public Benefit Corporation Announces Oversubscribed Series A Financing and Renames to Lykos Therapeutics | Psychedelic Invest
Funding comes from mission-aligned and institutional investors to support regulatory and pre-launch activities for investigational MDMA-assisted therapy for post-traumatic stress disorder (“PTSD”) Company rebrands and